Data Factory
Reading the graph
Reading the graph
Venture Capital
Cambridge, MA
Catalyzing Biodigital Innovation for Next-Gen Life Sciences Iaso Ventures Our Story Our name pays homage to the Greek goddess of recuperation from illness, Iaso, the daughter of Asclepius, the god of medicine. The rod of Asclepius, a snake-entwined staff, is…
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Iaso Neuroimpact Fund, L.P. | 2024 | Early deployment | $15.0M | $21.6M | 0 |
| Iaso Ventures, L.P. | n/a | Unknown | $0 | $15.9M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Beacon Biosignals, Inc. | Ma | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Aerska | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Inflection Medicine | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Axonis | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Neumirna Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Cadence Neuroscience | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Tuvahealth | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Zafrens | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Zeto | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Ryght | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| EpiWatch, Inc. | Md | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Catena Bio | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Celeri | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Mensura Health | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Neuraura | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Pragma | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Soovu | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Neurona Therapeutics, Inc | CA | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Deep 6 AI Inc. | CA | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Prudentiasciences | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Virtue Ventures Management L.L.C. | Iaso Ventures Management Firm LLC | 3 | 3 | Sep 16, 2026 | Recurring |
| Civilization Ventures Management, LLC | Iaso Ventures Management Firm LLC | 2 | 2 | Sep 16, 2026 | Recurring |
| Acequia Capital Management LLC | Iaso Ventures Management Firm LLC | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Iaso Ventures Management Firm LLC | 1 | 1 | Sep 16, 2026 | One time |
| AIX Ventures LLC | Iaso Ventures Management Firm LLC | 1 | 1 | Sep 16, 2026 | One time |
| Iaso Ventures Management Firm LLC | Catalio Capital Management, LP | 1 | 1 | Sep 16, 2026 | One time |
| GSR Ventures | Iaso Ventures Management Firm LLC | 1 | 1 | Sep 16, 2026 | One time |
| Iaso Ventures Management Firm LLC | Pledge Ventures Ltd | 1 | 1 | Sep 16, 2026 | One time |
| Life Sciences | Iaso Ventures Management Firm LLC | 1 | 1 | Sep 20, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Wasim Malik (Managing Partner), John Reynders (Chief Data Scientist & Venture Partner), Mark Currie (Venture Partner), Michael Fenn (Venture Partner), Sharon Tan (Executive in Residence), Anil Jina (Executive in Residence), Ray Sanchez (Advisor, Drug Development), Maurizio Fava (Advisor, Clinical R&D), Steve Schachter (Advisor, Medtech), Chandra Ramanathan (Advisor, Biotech), Noah Richmond (Advisor, Legal & IP), Wasim Q. Malik (Managing Partner).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan